Comparative Effectiveness Summit: Agenda: Preconference & Day I

AGENDA: PRECONFERENCE Wednesday, October 12, 2011 (Preconference optional; requires separate registration) Note, all times listed are Eastern Standard Time
PRECONFERENCE: COMMUNICATING COMPARATIVE EFFECTIVENESS DATA TO PHYSICIANS AND PATIENTS: ACADEMIC DETAILING AND SHARED DECISION MAKING
8:00 a.m.	Welcome and Introductions Michael A. Fischer, MD, MS Assistant Professor of Medicine, Harvard Medical School; Director, National Resource Center for Academic Detailing; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA (Co chair) Presentation Material (Acrobat)
8:15 a.m.	Bench to Behavior: Translating Comparative Effectiveness Research into Improved Clinical Practice Jerry Avorn, MD Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Author, Powerful Medicines: the Benefits, Risks, and Costs of Prescription Drugs (Knopf), Boston, MA Presentation Material (Acrobat)
8:45 a.m.	Improving Quality with CER Based Licensing and Certification Processes Lorna A. Lynn, MD Director of Practice Improvement Module Research, Staff Administrator, Conflict of Interest Committee, American Board of Internal Medicine, Philadelphia, PA Presentation Material (Acrobat)
9:15 a.m.	Shared Decision Making - Comparative Effectiveness in the Doctor-Patient Conversation Lyn Paget Director of Policy and Outreach, Foundation for Informed Medical Decision Making, Boston, MA Doris Peter, PhD Manager, Consumer Reports Ratings Center, Principal Investigator, Consumer and Prescriber Education Grant Project, Consumer Reports, Yonkers, NY Presentation Material (Acrobat)
10:00 a.m.	Break
10:15 a.m.	Models for Establishing Academic Detailing Programs to Increase Evidence-Based Prescribing Carol Havens, MD Director of Clinical Education, Kaiser Permanente Northern California, Sacramento, CA Presentation Material (Acrobat) Barry Patel, PharmD President and Co-Founder, Total Therapeutic Management, Kennesaw, GA Presentation Material (Acrobat) Tom Snedden Director, Pharmaceutical Assistance, Contract for the Elderly (PACE), Commonwealth of Pennsylvania, Harrisburg, PA Presentation Material (Acrobat) Michael A. Fischer, MD, MS Assistant Professor of Medicine, Harvard Medical School; Director, National Resource Center for Academic Detailing, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA (Moderator)
11:30 a.m.	Faculty Q&A and Wrap-Up Michael A. Fischer, MD, MS Assistant Professor of Medicine, Harvard Medical School; Director, National Resource Center for Academic Detailing, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA (Moderator)
12:00 p.m.	Adjournment and Lunch on Your Own
AGENDA: DAY I Wednesday, October 12, 2011
DAY I OPENING PLENARY SESSION: OVERVIEW AND THE ROLE OF GOVERNMENT IN COMPARATIVE EFFECTIVENESS RESEARCH
1:00 p.m.	Welcome and Overview of the Politics of Comparative Effectiveness Research Cliff Goodman, PhD Senior Vice President and Principal, The Lewin Group; Chair, Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), Centers for Medicare & Medicaid Services, Washington, DC (Co chair) Presentation Material (Acrobat)
1:15 p.m.	Update from the Patient-Centered Outcomes Research Institute Joe Selby, MD, MPH Director, Patient-Centered Outcomes Research Institute; Former Director of the Research Division, Kaiser Permanente, Northern California, Washington, DC Presentation Material (Acrobat)
2:00 p.m.	The Role of AHRQ in Comparative Effectiveness Research Carolyn M. Clancy, MD Director, Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, Washington, DC Presentation Material (Acrobat)
2:45 p.m.	The Role of NIH in Comparative Effectiveness Research Michael S. Lauer, MD, FACC, FAHA Director, NHLBI/Division of Cardiovascular Sciences, Bethesda, MD Presentation Material (Acrobat)
3:30 p.m.	Break
4:00 p.m.	How States are Using Comparative and Cost-Effective Research to Make Policy Decisions Mark Gibson Deputy Director, Center for Evidence-Based Policy, Oregon Health and Science University; Program Officer, Milbank Memorial Fund; Former Chief of Staff, Oregon Senate President John Kitzhaber, Portland, OR Presentation Material (Acrobat)
4:45 p.m.	The Advantages of Comparative Effectiveness Research Jerry Avorn, MD Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Author, Powerful Medicines: the Benefits, Risks, and Costs of Prescription Drugs (Knopf), Boston, MA Presentation Material (Acrobat)
5:30 p.m.	Comparative Effectiveness Research and Personalized Medicine Amy Miller Vice President, Public Policy, Personalized Medicine Coalition, Washington, DC Presentation Material (Acrobat)
6:15 p.m.	Adjournment